Physician profile
Ryan M Diaz
NPI 1841599404
$6,732.18
in general payments reported to CMS, 2019-2025
13 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,485 · 2020: $430 · 2021: $823 · 2022: $704 · 2023: $1,491 · 2024: $243 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419 · Travel and Lodging: $871.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.92 |
| Travel and Lodging | $871.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,421.86 | 2021-2025 | Prophecy, Invision, Inbone |
| Wright Medical Technology, INC. | $2,330.71 | 2019-2020 | |
| Bioventus LLC | $305.75 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $213.17 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $116.57 | 2019 | |
| Integra Lifesciences Corporation | $75.45 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Trilliant Surgical LLC. | $58.82 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Tiger Large Cannulated Instrument Module |
| Kerecis Limited | $49.87 | 2022 | |
| Abbvie INC. | $49.73 | 2025 | |
| Arthrosurface Incorporated | $41.54 | 2019 | |
| Calliditas Therapeutics US INC. | $36.49 | 2023 | |
| Acell, INC. | $16.16 | 2019 | |
| Misonix INC | $16.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.